| The use of therapeutic peptides to target and to kill cancer cells R J Boohaker, M W Lee, P Vishnubhotla, J LM Perez, A R Khaled Current medicinal chemistry 19 (22), 3794-3804, 2012 | 353 | 2012 |
| KIFC1 is a novel potential therapeutic target for breast cancer Y Li, W Lu, D Chen, RJ Boohaker, L Zhai, I Padmalayam, K Wennerberg, ... Cancer biology & therapy 16 (9), 1316-1322, 2015 | 146 | 2015 |
| Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment CL Haga, GRA Ehrhardt, RJ Boohaker, RS Davis, MD Cooper Proceedings of the National Academy of Sciences 104 (23), 9770-9775, 2007 | 118 | 2007 |
| The versatile functions of ATM kinase RJ Boohaker, B Xu Biomedical journal 37 (1), 3, 2014 | 72 | 2014 |
| GLI1: a therapeutic target for cancer JT Avery, R Zhang, RJ Boohaker Frontiers in oncology 11, 673154, 2021 | 57 | 2021 |
| Discovery of a novel inhibitor of kinesin-like protein KIFC1 W Zhang, L Zhai, Y Wang, RJ Boohaker, W Lu, VV Gupta, I Padmalayam, ... Biochemical Journal 473 (8), 1027-1035, 2016 | 52 | 2016 |
| BAX supports the mitochondrial network, promoting bioenergetics in nonapoptotic cells RJ Boohaker, G Zhang, AL Carlson, KN Nemec, AR Khaled American Journal of Physiology-Cell Physiology 300 (6), C1466-C1478, 2011 | 47 | 2011 |
| The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption MW Lee, R Bassiouni, NA Sparrow, A Iketani, RJ Boohaker, C Moskowitz, ... Cell death & disease 5 (5), e1249-e1249, 2014 | 46 | 2014 |
| Rational development of a cytotoxic peptide to trigger cell death RJ Boohaker, G Zhang, MW Lee, KN Nemec, S Santra, JM Perez, ... Molecular pharmaceutics 9 (7), 2080-2093, 2012 | 46 | 2012 |
| Apoptosis-induced alkalinization by the Na+/H+ exchanger isoform 1 is mediated through phosphorylation of amino acids Ser726 and Ser729 AL Grenier, K Abu-ihweij, G Zhang, SM Ruppert, R Boohaker, ER Slepkov, ... American Journal of Physiology-Cell Physiology 295 (4), C883-C896, 2008 | 42 | 2008 |
| Rational design and development of a peptide inhibitor for the PD-1/PD-L1 interaction RJ Boohaker, V Sambandam, I Segura, J Miller, M Suto, B Xu Cancer letters 434, 11-21, 2018 | 37 | 2018 |
| A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas N Liu, RJ Boohaker, C Jiang, JR Boohaker, B Xu Oncotarget 6 (33), 34649, 2015 | 30 | 2015 |
| KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC X Wei, S Cai, RJ Boohaker, J Fried, Y Li, L Hu, Y Pan, R Cheng, S Zhang, ... Endocrine-related cancer 26 (1), 141-151, 2019 | 25 | 2019 |
| ATM-mediated Snail Serine 100 phosphorylation regulates cellular radiosensitivity RJ Boohaker, X Cui, M Stackhouse, B Xu Radiotherapy and Oncology 108 (3), 403-408, 2013 | 22 | 2013 |
| A microRNA expression signature in taxane-anthracycline-based neoadjuvant chemotherapy response Y Zheng, S Li, RJ Boohaker, X Liu, Y Zhu, L Zhai, H Li, F Gu, Y Fan, ... Journal of Cancer 6 (7), 671, 2015 | 21 | 2015 |
| DNA mismatch repair protein Mlh1 is required for tetravalent chromium intermediate-induced DNA damage TP Wakeman, A Yang, NS Dalal, RJ Boohaker, Q Zeng, Q Ding, B Xu Oncotarget 8 (48), 83975, 2017 | 17 | 2017 |
| Induction of interleukin 10 by Borrelia burgdorferi is regulated by the action of CD14-dependent p38 mitogen-activated protein kinase and cAMP-mediated chromatin remodeling B Sahay, K Bashant, NLJ Nelson, RL Patsey, SK Gadila, R Boohaker, ... Infection and immunity 86 (4), 10.1128/iai. 00781-17, 2018 | 15 | 2018 |
| GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer R Zhang, J Ma, JT Avery, V Sambandam, TH Nguyen, B Xu, MJ Suto, ... Frontiers in oncology 10, 241, 2020 | 11 | 2020 |
| Discovery of Novel Allosteric Eg5 Inhibitors Through Structure‐Based Virtual Screening W Zhang, L Zhai, W Lu, RJ Boohaker, I Padmalayam, Y Li Chemical biology & drug design 88 (2), 178-187, 2016 | 10 | 2016 |
| Methods and compositions comprising a C-terminal Bax peptide A Khaled, R Boohaker, M Lee, JP Figueroa US Patent 9,040,662, 2015 | 7 | 2015 |
